Potent Oral Hypoglycemic Agents for Microvascular Complication: Sodium-Glucose Cotransporter 2 Inhibitors for Diabetic Retinopathy

Table 3

Logistic regression analysis of the effect of different variables on the progression of DR before propensity score matching in the SGLT2i and control groups.

Variable	OR (95% CI)	value
Age	0.985 (0.951-1.021)	0.411
Sex (female)	1.455 (0.617-3.428)	0.392
Duration of diabetes	0.965 (0.919-1.015)	0.165
Hypertension	0.774 (0.331-1.808)	0.554
CVD	0.705 (0.170-2.929)	0.631
SGLT2i	0.215 (0.058-0.796)	0.021
HbA1c	1.041 (0.841-1.288)	0.714
Total cholesterol	1.000 (0.991-1.009)	0.944
Triglycerides	0.996 (0.991-1.002)	0.178
HDL cholesterol	0.954 (0.907-1.003)	0.067
LDL cholesterol	1.004 (0.991-1.017)	0.589

Data are presented as odd ratios (95% confidence interval). CVD = cardiovascular disease; HDL = high-density lipoprotein; LDL = low-density lipoprotein; SGLT2i = sodium-glucose cotransporter 2 inhibitor. .